Powell’s ‘been dealt an insanely bad hand’ in the inflation fight, Jim Cramer says


CNBC’s Jim Cramer defended Federal Reserve Chair Jerome Powell Monday after the central bank chief promised aggressive action on inflation.

“Powell’s been dealt an insanely bad hand. So of course he’s fallen behind. Hence why he’s said that the Fed will move with alacrity from here on out,” the “Mad Money” host said. “So feel free to blame him for not seeing what was coming. If he has to do a [50 basis point interest rate hike], he will.”

“Never forget that Powell’s been asked to do the impossible here: Figure out how fast to raise interest rates when so many things should be slowing the economy and cooling inflation naturally, yet nothing has worked out the way we expected,” he added.

Powell on Monday pledged that the Fed will take strong action against surging inflation, which is currently at its highest level in 40 years. Powell said rate hikes bigger than a quarter-percentage point are possible and hikes will continue until inflation is under control.

His strong stance against inflation, which comes one week after the Fed raised interest rates for the first time in more than three years, led the market to teeter Monday, ending a multiday streak of gains. The Dow Jones Industrial Average dipped 0.6%, while the S&P 500 slipped 0.04%. The Nasdaq Composite dropped 0.4%.

Listing a bevy of recent market shakers — including the current housing shortage, the semiconductor chip shortage, healthy consumer spending, Covid fears and Russia’s invasion of Ukraine — Cramer reiterated that these unprecedented times have made it difficult for Powell to anticipate what will strike the market next.

Cramer added that he believes it’s unfair for investors to expect Powell to predict the path of the pandemic.

“At the end of the day, public health is outside of the Fed’s purview,” Cramer said.



Source

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More
American Express, credit card provider to the wealthy, wants even more high spenders
Business

American Express, credit card provider to the wealthy, wants even more high spenders

American Express announces the new platinum business card. Courtesy: American Express American Express is finding that even for a provider of credit cards to the affluent, it pays to focus on the highest of high rollers. The company recently shifted marketing dollars to its refreshed Platinum card, which carries an $895 annual fee, and away […]

Read More